3.66 USD
↘ 0.21 (5.43%)AT CLOSE (11:59 AM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock
ZNTLNASDAQ • USD
3.60
↘ 0.07 (1.78%)
POST MARKET (AS OF 07:41 PM EDT)
Post Market
AS OF 07:41 PM EDT
3.60
↘ 0.07 (1.78%)
Market: CLOSED
Open?$3.85
High?$3.85
Low?$3.42
Prev. Close?$3.87
Volume?1.0M
Avg. Volume?964.0K
VWAP?$3.62
Rel. Volume?1.05x
Bid / Ask
Bid?$3.59 × 200
Ask?$3.87 × 300
Spread?$0.28
Midpoint?$3.73
Valuation & Ratios
Market Cap?260.5M
Shares Out?71.2M
Float?46.7M
Float %?64.6%
P/E Ratio?N/A
P/B Ratio?1.43
EPS?-$1.74
Dividend?0.00%
Ex-Dividend?N/A
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $3.66. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
260.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.59Distress
Confidence?56%Low
Short InterestHigh
Short % of Float?10.55%High
Short Interest?4.9M
Days to Cover?5.5
Free Float46.7M
Avg Daily Volume889.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?6.19Strong
Quick Ratio?6.19Strong
Cash Ratio?0.91Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.43CHEAP▾
Peers100
S&P89
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-68.0%WEAK▾
S&P3
ROA?-49.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-125601000
Enterprise Value?$228.6M
Fundamentals ratios updated end of day